Advanced Enzyme Technologies reported strong financial performance for Q4 FY26 and the full fiscal year.

For Q4, revenue grew 22% year-on-year to ₹203.4 Cr, with profit after tax (PAT) soaring 69% to ₹45.3 Cr.

Full FY26 revenue increased 17% to ₹745.8 Cr, and PAT climbed 30% to ₹173.6 Cr.

Human Nutrition was a key growth segment, contributing 63% to Q4 revenue with a 24% year-on-year rise.

India sales surged 51% in Q4, becoming the largest geographical contributor, though the Americas segment saw an 11% decline.

Looking ahead, the company plans continued investment in R&D to develop new enzyme and probiotic solutions for high-return applications, aiming for broader global presence through strategic partnerships and inorganic expansion.

Specific focus areas include expanding offerings in animal nutrition and probiotics, developing bio-catalysis solutions for API manufacturers, and growing baking solutions worldwide.

Q4 FY26 earnings per share (EPS) rose 62% to ₹3.84, while full-year EPS increased 29% to ₹15.08.